Anti-Cytokeratin 19 antibody [BA16]
- BOND RX™ Validated
- What is this?
5
(2 Reviews)
|
(5 Publications)
Mouse Monoclonal Cytokeratin 19 antibody. Suitable for IHC-P, ICC, WB, ICC/IF and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [BA16] (AB20210)
IHC image of Cytokeratin 19 staining in human normal liver formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab20210, 5μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- ICC
AbReview15922****
Immunocytochemistry - Anti-Cytokeratin 19 antibody [BA16] (AB20210)
ab20210 at 1/100 dilution staining Cytokeratin 19 breast cancer cell line by immunocytochemistry. Sections were methanol fixed prior to blocking in 10% serum for 5 minutes and then incubated with ab20210, for 1 hour at 25°C. Ultravision ONE HRP rabbit polyclonal to mouse Ig was used as the secondary antibody.
This image is courtesy of an Abreview submitted by Rene Villadsen
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [BA16] (AB20210)
ab20210 staining Cytokeratin 19 in HepG2 cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab20210 at 5µg/ml and ab6046, Rabbit polyclonal to beta Tubulin - Loading Control. Cells were then incubated with ab150117, Goat polyclonal Secondary Antibody to Mouse IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 dilution (shown in green) and ab150080, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 594) at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue).
Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.
- WB
Lab
Western blot - Anti-Cytokeratin 19 antibody [BA16] (AB20210)
All lanes:
Anti-Cytokeratin 19 antibody [BA16] (ab20210) at 1 µg/mL
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
Human liver tissue lysate - total protein (<a href='/en-us/products/unavailable/human-liver-tissue-lysate-total-protein-ab29889'>ab29889</a>) at 10 µg
Lane 3:
Human tonsil normal tissue lysate - total protein (<a href='/en-us/products/unavailable/human-tonsil-normal-tissue-lysate-total-protein-ab29615'>ab29615</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution
Predicted band size: 44 kDa
Observed band size: 40 kDa,44 kDa
true
Exposure time: 1min
Reactivity data
Product details
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.
Pathways
CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Breast cancer research : BCR 26:183 PubMed39695857
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pathology 257:607-619 PubMed35373359
2022
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 22:102 PubMed32993755
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:10580-10593 PubMed28076334
2017
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 18:108 PubMed27809866
2016
Applications
Unspecified application
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com